Clinical Trial Update: Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating transcatheter valve implantation for severe tricuspid regurgitation in advanced heart failure was terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Tricuspid Regurgitation

Drugs mentioned

• Edwards Sapien XT Valve

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Severe Tricuspid Regurgitation | Phase 2, Phase 3 | Status: TERMINATED